All lobbying filings
ARENTFOX SCHIFF LLP
Lobbying for PHARVARIS, INC. · Late-stage biopharmaceutical company
Filing
4th Quarter - Report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 20, 2026
Income
$30,000.00
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
1
-
KELSEY GRISWOLD-BERGER New on this filingPreviously held: Sr Policy Advisor, Sen McCormick (2025); LA, Sen Burr (2021-23); Leg Dir, Rep C Smith (2018-21); Leg Dir, Rep Pittenger (2018); Leg Dir, Rep Blum (2017-18); LA, Rep Perry (2015-17); LA (2014-15), LC/Press Asst (2011-14), SA (2011), Rep Reed
Government bodies contacted
2
Lobbying activity
2
Advocacy of policies, legislation and coverage of new pharmaceuticals in the orphan drug space.
Advocacy of policies, legislation and regulation pertaining to pharmaceutical manufacturing, focusing on orphan drug production.